NCT02199743View on ClinicalTrials.gov

Lurasidone Effects on Tissue Glutamate in Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

Lurasidone

Compare to haloperidol and perphenazine

DRUG

Haloperidol

Compare to lurasidone

DRUG

Perphenazine

Compare to lurasidone

Trial Locations (1)

75390

UT Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

Sumitomo Pharma America, Inc.

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER

NCT02199743 - Lurasidone Effects on Tissue Glutamate in Schizophrenia | Biotech Hunter | Biotech Hunter